Novavax Stock Jumps On FDA Covid Vaccine Filing Plan By Year End

Novavax shares jumped higher Monday after the drugmaker said it will file a package of data linked to its developing coronavirus vaccine with the U.S. Food & Drug Administration by the end of the year.

Related Keywords

Mexico ,United Arab Emirates ,United Kingdom ,Stanley Erck ,Us Food Drug Administration ,European Medicines Agency ,Novavax Inc ,Drug Administration ,Emergency Use Authorization ,United Arab Emirates Monday ,Stock Market Futures ,Pharmaceuticals ,Investing ,Markets ,Drug Approvals ,Stocks ,Futures ,